Jazz Pharmaceuticals target price raised to $291 from $286 by Truist Securities
JAZZ•Truist Securities raised its target price for Jazz Pharmaceuticals to $291 from $286.
Related News
Baird cuts Bright Minds Biosciences target price to $107 from $126
DRUG•
Gold eases ahead of US midterm elections
GLD•
AllianceBernstein Holding LP: BofA Global Research cuts price objective to $34 from $35
AB•
D.A. Davidson raises ACI Worldwide price target to $72 from $66
ACIW•
BofA Global Research cuts Axsome Therapeutics price objective to $264 from $276
AXSM•